SCHEMBL25820637

SCHEMBL25820637

Cc1ccc(C(=O)Nc2cccc(Nc3ccccc3)c2)cc1Nc1ccnc2ccc(F)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 7/20 0.53
DNMT3A Q9Y6K1 6/20 0.53
DNMT3L Q9UJW3 4/20 0.51
EHMT1 Q9H9B1 2/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49
APEX1 P27695 1/20 0.49
RET P07949 1/20 0.49
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
LDLR P01130 1/20 0.46
KIT P10721 1/20 0.46
PCSK9 Q8NBP7 1/20 0.46
KCNK3 O14649 2/20 0.46
KCNK9 Q9NPC2 1/20 0.46
BRAF P15056 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30290879 0.95 DNMT1 (0.52) DNMT1DNMT3ADNMT3LEHMT1POLB
SCHEMBL24011037 0.95 DNMT1 (0.52) DNMT1DNMT3ADNMT3LEHMT1POLB
SCHEMBL25820651 0.91 DNMT1 (0.64) DNMT1DNMT3ADNMT3LEHMT1MEN1
SCHEMBL25820658 0.91 DNMT1 (0.55) DNMT1DNMT3ADNMT3LEHMT1POLB
SCHEMBL30290755 0.88 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1MAPT
SCHEMBL24011122 0.88 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1MAPT
SCHEMBL25820533 0.88 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1MAPT
SCHEMBL24003883 0.88 DNMT1 (0.62) DNMT1DNMT3ADNMT3LEHMT1POLB
SCHEMBL24003803 0.87 DNMT1 (0.52) DNMT1DNMT3ADNMT3LEHMT1POLB
SCHEMBL25820646 0.87 DNMT1 (0.61) DNMT1DNMT3ADNMT3LEHMT1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885DNMT3L 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.